CTP-guided reperfusion therapy in acute ischemic stroke: a meta-analysis.


Journal

Acta neurologica Scandinavica
ISSN: 1600-0404
Titre abrégé: Acta Neurol Scand
Pays: Denmark
ID NLM: 0370336

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 28 09 2020
revised: 08 11 2020
accepted: 09 11 2020
pubmed: 15 11 2020
medline: 11 5 2021
entrez: 14 11 2020
Statut: ppublish

Résumé

Computed tomography perfusion (CTP) imaging could be useful in guiding reperfusion therapy or patient selection in acute ischemic stroke (AIS) patients. The aim of the current study was to determine the efficacy of the CTP-guided reperfusion therapy in AIS by performing a systematic review and meta-analysis. Medline/PubMed, Embase, and the Cochrane library were searched using the terms: "CT perfusion", "acute stroke" and "reperfusion therapy". The following studies were included: (a) studies reporting original data; (b) patients aged 18 years or above; (c) patients diagnosed with anterior circulation AIS; and (d) studies with good methodological design. Twenty-two studies were finally included in the metanalysis with a total of 5, 687 patients. CTP-guided reperfusion therapy was associated with increased odds of good functional outcome without significant difference in safety profile. CTP-guided reperfusion therapy improved functional outcomes in AIS, with increased benefits to patients treated with endovascular thrombectomy.

Sections du résumé

BACKGROUND BACKGROUND
Computed tomography perfusion (CTP) imaging could be useful in guiding reperfusion therapy or patient selection in acute ischemic stroke (AIS) patients. The aim of the current study was to determine the efficacy of the CTP-guided reperfusion therapy in AIS by performing a systematic review and meta-analysis.
METHODS METHODS
Medline/PubMed, Embase, and the Cochrane library were searched using the terms: "CT perfusion", "acute stroke" and "reperfusion therapy". The following studies were included: (a) studies reporting original data; (b) patients aged 18 years or above; (c) patients diagnosed with anterior circulation AIS; and (d) studies with good methodological design.
RESULTS RESULTS
Twenty-two studies were finally included in the metanalysis with a total of 5, 687 patients. CTP-guided reperfusion therapy was associated with increased odds of good functional outcome without significant difference in safety profile.
CONCLUSIONS CONCLUSIONS
CTP-guided reperfusion therapy improved functional outcomes in AIS, with increased benefits to patients treated with endovascular thrombectomy.

Identifiants

pubmed: 33188539
doi: 10.1111/ane.13374
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

355-366

Subventions

Organisme : NSW Ministry of Health
ID : 2019-2022

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Feigin VL, Nichols E, Alam T, et al. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459-480.
Seshadri S, Beiser A, Kelly-Hayes M, et al. The lifetime risk of stroke. Stroke. 2006;37(2):345-350.
Bhaskar S, Stanwell P, Cordato D, Attia J, Levi C. Reperfusion therapy in acute ischemic stroke: dawn of a new era? BMC Neurol. 2018;18(1):8.
Powers William J, Rabinstein Alejandro A, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418.
Gabrielli A, Layon AJ, Yu M. Civetta, Taylor, & Kirby's Manual of Critical Care. Philadelphia, PA: Lippincott Williams & Wilkins; 2012.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue Plasminogen Activator for Acute Ischemic Stroke. N Engl J Med. 1995;333(24):1581-1588.
Ravindran AV, Killingsworth MC, Bhaskar S. Cerebral collaterals in acute ischaemia: Implications for acute ischaemic stroke patients receiving reperfusion therapy. Eur J Neurosci. 2020;1-24.
Muir KW, Ford GA, Messow C-M, et al. Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial. J Neurol Neurosurg Psychiatry. 2017;88(1):38-44.
Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296-2306.
Saver JL, Goyal M, Bonafe A, et al. Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke. N Engl J Med. 2015;372(24):2285-2295.
Bracard S, Ducrocq X, Mas JL, et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016;15(11):1138-1147.
Ezzeddine MA, Lev MH, McDonald CT, et al. CT angiography with whole brain perfused blood volume imaging: added clinical value in the assessment of acute stroke. Stroke. 2002;33(4):959-966.
Konstas AA, Goldmakher GV, Lee TY, Lev MH. Theoretic Basis and Technical Implementations of CT Perfusion in Acute Ischemic Stroke, Part 1: Theoretic Basis. Am J Neuroradiol. 2009;30(4):662.
Campbell BCV, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009-1018.
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378(8):708-718.
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378(1):11-21.
Oremus M, Wolfson C, Perrault A, Demers L, Momoli F, Moride Y. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement Geriatr Cogn Disord. 2001;12(3):232-236.
Saunders R, Struys M, Pollock RF, Mestek M, Lightdale JR. Patient safety during procedural sedation using capnography monitoring: a systematic review and meta-analysis. BMJ open. 2017;7(6):e013402.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.
Jadhav AP, Aghaebrahim A, Jankowitz BT, et al. Benefit of Endovascular Thrombectomy by Mode of Onset: Secondary Analysis of the DAWN Trial. Stroke. 2019;50(11):3141-3146.
Ryu WHA, Avery MB, Dharampal N, Allen IE, Hetts SW. Utility of perfusion imaging in acute stroke treatment: a systematic review and meta-analysis. J NeuroIntervent Surg. 2017;9(10):1012-1016.
Sztriha LK, Manawadu D, Jarosz J, Keep J, Kalra L. Safety and clinical outcome of thrombolysis in ischaemic stroke using a perfusion CT mismatch between 3 and 6 hours. PLoS One. 2011;6(10):e25796.
Morelli N, Rota E, Immovilli P, et al. Computed tomography perfusion-based thrombolysis in wake-up stroke. Intern Emerg Med. 2015;10(8):977-984.
Sim K, Yan B, Dowling R, Bush S, Mitchell P. Endovascular clot retrieval in acute stroke with large ischaemic core is not always associated with poor outcomes. Intern Med J. 2019;49(4):490-494.
Campbell BCV, Majoie CBLM, Albers GW, et al. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data. Lancet Neurol. 2019;18(1):46-55.
The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke (TESLA). https://www.clinicaltrials.gov/ct2/show/NCT03805308. Accessed 28 February, 2020
Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window (TENSION). https://clinicaltrials.gov/ct2/show/NCT03094715. Accessed 28 February, 2020
Large Stroke Therapy Evaluation (LASTE). https://clinicaltrials.gov/ct2/show/NCT03811769. Accessed 28 February, 2020
SELECT 2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke. https://clinicaltrials.gov/ct2/show/NCT03876457. Accessed 28 February, 2020
Medina-Rodriguez M, Millan-Vazquez M, Zapata-Arriaza E, et al. Intravenous Thrombolysis Guided by Perfusion CT with Alteplase in >4.5 Hours from Stroke Onset. Cerebrovascular Diseases. 2020;49(3):328-333.
Sabarudin A, Subramaniam C, Sun Z. Cerebral CT angiography and CT perfusion in acute stroke detection: a systematic review of diagnostic value. Quant Imaging Med Surg. 2014;4(4):282-290.
Bhaskar S, Bivard A, Parsons M, et al. Delay of late-venous phase cortical vein filling in acute ischemic stroke patients: Associations with collateral status. J Cereb Blood Flow Metab. 2017;37(2):671-682.
Bhaskar S, Bivard A, Stanwell P, et al. Association of cortical vein filling with clot location and clinical outcomes in acute ischaemic stroke patients. Sci Rep. 2016;6:38525.
Bhaskar S, Bivard A, Stanwell P, et al. Baseline collateral status and infarct topography in post-ischaemic perilesional hyperperfusion: An arterial spin labelling study. J Cereb Blood Flow Metab. 2017;37(3):1148-1162.
Bhaskar S, Sharma D, Walker AH, et al. Acute Neurological Care in the COVID-19 Era: The Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium Pathway. Front Neurol. 2020;11:579.
Bhaskar S, Bradley S, Israeli-Korn S, et al. Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium. Front Neurol. 2020;11:664.
Bhaskar S, Sinha A, Banach M, et al. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Front Immunol. 2020;11:1648.
Ma H, Campbell BCV, Parsons MW, et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med. 2019;380(19):1795-1803.
Campbell BC, Christensen S, Levi CR, et al. Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke. Stroke. 2012;43(10):2648-2653.
Bivard A, Levi C, Krishnamurthy V, et al. Perfusion computed tomography to assist decision making for stroke thrombolysis. Brain. 2015;138(Pt 7):1919-1931.
Obach V, Oleaga L, Urra X, et al. Multimodal CT-assisted thrombolysis in patients with acute stroke: A cohort study. Stroke. 2011;42(4):1129-1131.
Turk AS, Magarick JA, Frei D, et al. CT perfusion-guided patient selection for endovascular recanalization in acute ischemic stroke: a multicenter study. J Neurointervent Surg. 2013;5(6):523-527.
Garcia-Bermejo P, Calleja AI, Perez-Fernandez S, et al. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study. Cerebrovasc Dis (Basel, Switzerland). 2012;34(1):31-37.
Bouslama M, Haussen DC, Grossberg JA, et al. Computed tomographic perfusion selection and clinical outcomes after endovascular therapy in large vessel occlusion stroke. Stroke. 2017;48(5):1271-1277.
Furlanis G, Ajčević M, Buoite Stella A, et al. Wake-up stroke: thrombolysis reduces ischemic lesion volume and neurological deficit. J Neurol. 2020;267(3):666-673.
Natarajan SK, Karmon Y, Snyder KV, et al. Prospective acute ischemic stroke outcomes after endovascular therapy: a real-world experience. World Neurosurg. 2010;74(4):455-464.
Medina-Rodriguez M, Millan-Vazquez M, Zapata-Arriaza E, et al. Intravenous Thrombolysis Guided by Perfusion CT with Alteplase in & #x3e;4.5 Hours from Stroke Onset. Cerebrovasc Dis. 2020;49(3):328-333.
Hassan AE, Zacharatos H, Rodriguez GJ, et al. A comparison of computed tomography perfusion-guided and time-guided endovascular treatments for patients with acute ischemic stroke. Stroke. 2010;41(8):1673-1678.
Prabhakaran S, Soltanolkotabi M, Honarmand AR, et al. Perfusion-based selection for endovascular reperfusion therapy in anterior circulation acute ischemic stroke. AJNR Am J Neuroradiol. 2014;35(7):1303-1308.
Menjot De Champfleur N, Saver JL, Goyal M, et al. Efficacy of Stent-Retriever Thrombectomy in Magnetic Resonance Imaging Versus Computed Tomographic Perfusion-Selected Patients in SWIFT PRIME Trial (Solitaire FR with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke). Stroke. 2017;48(6):1560-1566.
Abou-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke. 2010;41(9):1996-2000.
Rai AT, Raghuram K, Domico J, Hobbs G, Carpenter J. Pre-intervention triage incorporating perfusion imaging improves outcomes in patients undergoing endovascular stroke therapy: a comparison with the device trials. J Neurointervent Surg. 2013;5(2):121.
Ng FC, Coote S, Frost T, Bladin C, Choi PM. Utility of computed tomographic perfusion in thrombolysis for minor stroke. Stroke. 2016;47(7):1914-1916.
Wannamaker R, Guinand T, Menon BK, et al. Computed tomographic perfusion predicts poor outcomes in a randomized trial of endovascular therapy. Stroke. 2018;49(6):1426-1433.
Borst J, Berkhemer OA, Roos YB, et al. Value of computed tomographic perfusion-based patient selection for intra-arterial acute ischemic stroke treatment. Stroke. 2015;46(12):3375-3382.

Auteurs

Anubhav Katyal (A)

Neurovascular Imaging Laboratory, Ingham Institute for Applied Medical Research, Clinical Sciences Stream, Sydney, NSW, Australia.
University of New South Wales (UNSW, South Western Sydney Clinical School, Sydney, NSW, Australia.

Sonu Bhaskar (S)

Neurovascular Imaging Laboratory, Ingham Institute for Applied Medical Research, Clinical Sciences Stream, Sydney, NSW, Australia.
University of New South Wales (UNSW, South Western Sydney Clinical School, Sydney, NSW, Australia.
Department of Neurology & Neurophysiology, Liverpool Hospital & South Western Sydney Local Health District, Sydney, NSW, Australia.
Stroke & Neurology Research Group, Ingham Institute for Applied Medical Research, Sydney, NSW, Australia.
NSW Brain Clot Bank, NSW Health Statewide Biobank and NSW Health Pathology, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH